eClinical Tech News

AC Immune has completed a strategic review, narrowed its investment focus to three Phase 2 active immunotherapies and a...

Rhythm Pharmaceuticals reported third-quarter 2025 net product revenue of $51.3 million and, more importantly, secured FDA priority review for...

Taysha Gene Therapies has secured FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome, finalized alignment with the agency...

Kura Oncology has advanced its menin inhibitor, ziftomenib, on two fronts at once: the FDA is reviewing the new...

Pyxis Oncology will deliver preliminary Phase 1 data in the fourth quarter of 2025 for micvotabart pelidotin, a first-in-concept...

Krystal Biotech reported third-quarter 2025 net product revenue of $97.8 million from Vyjuvek, expanded the U.S. label to include...

Kamada will report third-quarter and nine-month 2025 results before the U.S. market opens on November 10, with an investor...

Psyence Biomedical has made a $3.5 million follow-on investment in Psylabs, a producer of purified psychedelic active pharmaceutical ingredients,...

TG Therapeutics reported third-quarter 2025 revenue of $161.7 million, including $152.9 million in U.S. Briumvi net sales. It raised...

BioCryst posted a profitable third quarter on the back of Orladeyo, raised full‑year guidance, completed the sale of its...